go back

Indiana rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $0 · 10th–90th $0–$1,659,5870%50%90th$0Professionalmedian $588,844 · 10th–90th $588,844–$645,6540%50%90th$588,844$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$588,843.66 / $1,659,586.91 / $2,691,534.80
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $616,595.00
Anthem BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.02 / $0.02 / $691,830.97
Anthem BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $1,148,153.62
CareSource
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $851,138.04 / $1,122,018.45
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$1,096,478.20 / $1,096,478.20 / $1,096,478.20
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$549,540.87 / $588,843.66 / $1,000,000.00